ECOG-ACRIN EAZ171: Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TIPN) in Black women with early-stage breast cancer.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Tarah Jean Ballinger, Fengmin Zhao, Joseph A. Sparano, Sofia F. Garcia, Fei Shen, Shamsuddin Virani, Jayanthi Srinivasiah, Erica Michelle Stringer-Reasor, Ami Chitalia, Andrew A. Davis, Della F. Makower, Jason Incorvati, Melissa A. Simon, Edith P. Mitchell, Angela DeMichele, Kathy Miller, Lynne I. Wagner, Antonio C. Wolff, Bryan P. Schneider
Institutions: Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Dana-Farber Cancer Institute, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, Northwestern University, Aurora Health Care, Georgia Cancer Specialists, University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center, MedStar Washington Hospital Center, Washington University in St. Louis, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, Fox Chase Cancer Center, Thomas Jefferson University Hospital, Sidney Kimmel Cancer Center, University of Pennsylvania, University of North Carolina at Chapel Hill, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399452807